Could a smart glucose meter transform diabetes care?

NCT ID NCT07774078

NEW Recruiting now Disease control Sponsor: University of Monastir Source: ClinicalTrials.gov ↗

First seen Aug 19, 2026 · Last updated Aug 19, 2026

Summary

This trial tests whether remote monitoring can help people with diabetes better control their blood sugar. Participants will either use a connected glucose meter that sends readings to a platform for remote management, or receive standard care. The study will compare changes in blood sugar and HbA1c levels over six months to see if telemonitoring makes a difference.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Telemonitoring with a connected blood glucose meter and mobile/web platform
What this could lead to: If effective, this approach could offer a practical way to help people with diabetes manage their blood sugar more effectively from home.
What could go wrong: The trial is relatively small and results may not apply to all diabetes patients. Success depends on patients consistently using the technology.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETE MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETE MELLITUS TELEMONITORING

Contacts and locations

Locations

University Hospital Fattouma Bourguiba Monastir
RECRUITING

Monastir, Tunisia

More trials for these conditions

Other studies related to the condition(s) this trial covers.